Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA HCl and SFC with ACT in Uncomplicated Malaria
NCT04020653Phase 2Withdrawn
- Sponsor
- Neopharma
- Start
- Sep 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of 5-aminolevulinic acid, sodium ferrous citrate in malaria, sponsored by Neopharma. Planned start Sep 2019; status: withdrawn.
02
Drugs
5-aminolevulinic acidsodium ferrous citrate
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04020653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020653.